The role of cytokines in the pathogenesis and treatment of HIV infection

Cytokine and Growth Factor Reviews

Volumn 23, Issue 4-5, 2012, Pages 207-214

  Catalfamo, Marta ^a   Le Saout, Cecile ^a   Lane, H Clifford ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

CD4 and CD8 T cell immune activation; IL 7; T cell homeostasis; Type I IFN

Indexed keywords

ALPHA INTERFERON; CD14 ANTIGEN; CYTOKINE; D DIMER; INTERFERON; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 7; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; ARTICLE; CD4 CD8 RATIO; COMBINATION CHEMOTHERAPY; CYTOKINE RESPONSE; DISEASE ASSOCIATION; DRUG DESIGN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; INFLAMMATION; KAPOSI SARCOMA; LIFE EXPECTANCY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RNA ANALYSIS; T LYMPHOCYTE ACTIVATION; TISSUE LEVEL; VIRUS REPLICATION;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; VIRAL LOAD;

EID: 84864924083     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2012.05.007     Document Type: Article

References (106)

1. Veazey R.S., DeMaria M., Chalifoux L.V., Shvetz D.E., Pauley D.R., Knight H.L., et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science (New York, NY) 1998, 280:427-431.
2. Brenchley J.M., Schacker T.W., Ruff L.E., Price D.A., Taylor J.H., Beilman G.J., et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. The Journal of Experimental Medicine 2004, 200:749-759.
3. Mehandru S., Poles M.A., Tenner-Racz K., Horowitz A., Hurley A., Hogan C., et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. The Journal of Experimental Medicine 2004, 200:761-770.
4. Li Q., Duan L., Estes J.D., Ma Z.M., Rourke T., Wang Y., et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 2005, 434:1148-1152.
5. Mattapallil J.J., Douek D.C., Hill B., Nishimura Y., Martin M., Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005, 434:1093-1097.
6. Brinchmann J.E., Albert J., Vartdal F. Few infected CD4+ T cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type 1 infection. Journal of Virology 1991, 65:2019-2023.
7. Haase A.T., Henry K., Zupancic M., Sedgewick G., Faust R.A., Melroe H., et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science (New York, NY) 1996, 274:985-989.
8. Chun T.W., Carruth L., Finzi D., Shen X., DiGiuseppe J.A., Taylor H., et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997, 387:183-188.
9. Haase A.T. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. Annual Review of Immunology 1999, 17:625-656.
10. Lane H.C., Masur H., Edgar L.C., Whalen G., Rook A.H., Fauci A.S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. The New England Journal of Medicine 1983, 309:453-458.
11. Lane H.C., Fauci A.S. Immunologic abnormalities in the acquired immunodeficiency syndrome. Annual Review of Immunology 1985, 3:477-500.
12. Ascher M.S., Sheppard H.W. AIDS as immune system activation: a model for pathogenesis. Clinical and Experimental Immunology 1988, 73:165-167.
13. Giorgi J.V., Hultin L.E., McKeating J.A., Johnson T.D., Owens B., Jacobson L.P., et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. The Journal of Infectious Diseases 1999, 179:859-870.
14. Douek D.C., Brenchley J.M., Betts M.R., Ambrozak D.R., Hill B.J., Okamoto Y., et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002, 417:95-98.
15. Deeks S.G., Kitchen C.M., Liu L., Guo H., Gascon R., Narvaez A.B., et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 2004, 104:942-947.
16. Doisne J.M., Urrutia A., Lacabaratz-Porret C., Goujard C., Meyer L., Chaix M.L., et al. CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection. Journal of Immunology 2004, 173:2410-2418.
17. Fauci A.S., Mavilio D., Kottilil S. NK cells in HIV infection: paradigm for protection or targets for ambush. Nature Reviews 2005, 5:835-843.
18. Derdeyn C.A., Silvestri G. Viral and host factors in the pathogenesis of HIV infection. Current Opinion in Immunology 2005, 17:366-373.
19. Brenchley J.M., Price D.A., Douek D.C. HIV disease: fallout from a mucosal catastrophe?. Nature Immunology 2006, 7:235-239.
20. van Grevenynghe J., Cubas R.A., Noto A., Dafonseca S., He Z., Peretz Y., et al. Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosis. The Journal of Clinical Investigation 2011, 121:3877-3888.
21. Lempicki R.A., Kovacs J.A., Baseler M.W., Adelsberger J.W., Dewar R.L., Natarajan V., et al. Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:13778-13783.
22. McCune J.M., Hanley M.B., Cesar D., Halvorsen R., Hoh R., Schmidt D., et al. Factors influencing T-cell turnover in HIV-1-seropositive patients. The Journal of Clinical Investigation 2000, 105:R1-R8.
23. Kovacs J.A., Lempicki R.A., Sidorov I.A., Adelsberger J.W., Herpin B., Metcalf J.A., et al. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. The Journal of Experimental Medicine 2001, 194:1731-1741.
24. Fleury S., de Boer R.J., Rizzardi G.P., Wolthers K.C., Otto S.A., Welbon C.C., et al. Limited CD4+T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy. Nature Medicine 1998, 4:794-801.
25. Hazenberg M.D., Hamann D., Schuitemaker H., Miedema F. T cell depletion in HIV-1 infection: how CD4+T cells go out of stock. Nature Immunology 2000, 1:285-289.
26. Ho H.N., Hultin L.E., Mitsuyasu R.T., Matud J.L., Hausner M.A., Bockstoce D., et al. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. Journal of Immunology 1993, 150:3070-3079.
27. Kestens L., Vanham G., Vereecken C., Vandenbruaene M., Vercauteren G., Colebunders R.L., et al. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection. Clinical and Experimental Immunology 1994, 95:436-441.
28. Mahalingam M., Peakman M., Davies E.T., Pozniak A., McManus T.J., Vergani D. T cell activation and disease severity in HIV infection. Clinical and Experimental Immunology 1993, 93:337-343.
29. Hazenberg M.D., Otto S.A., van Benthem B.H., Roos M.T., Coutinho R.A., Lange J.M., et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS (London, England) 2003, 17:1881-1888.
30. Gordon S.N., Klatt N.R., Bosinger S.E., Brenchley J.M., Milush J.M., Engram J.C., et al. Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys. Journal of Immunology 2007, 179:3026-3034.
31. Pandrea I.V., Gautam R., Ribeiro R.M., Brenchley J.M., Butler I.F., Pattison M., et al. Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence. Journal of Immunology 2007, 179:3035-3046.
32. Chahroudi A., Bosinger S.E., Vanderford T.H., Paiardini M., Silvestri G. Natural SIV hosts: showing AIDS the door. Science (New York, NY) 2012, 335:1188-1193.
33. Kuller L.H., Tracy R., Belloso W., De Wit S., Drummond F., Lane H.C., et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Medicine 2008, 5:e203.
34. Sachsenberg N., Perelson A.S., Yerly S., Schockmel G.A., Leduc D., Hirschel B., et al. Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. The Journal of Experimental Medicine 1998, 187:1295-1303.
35. Zhang Z.Q., Notermans D.W., Sedgewick G., Cavert W., Wietgrefe S., Zupancic M., et al. Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:1154-1159.
36. Ho D.D., Neumann A.U., Perelson A.S., Chen W., Leonard J.M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
37. Sieg S.F., Rodriguez B., Asaad R., Jiang W., Bazdar D.A., Lederman M.M. Peripheral S-phase T cells in HIV disease have a central memory phenotype and rarely have evidence of recent T cell receptor engagement. The Journal of Infectious Diseases 2005, 192:62-70.
38. Mohri H., Perelson A.S., Tung K., Ribeiro R.M., Ramratnam B., Markowitz M., et al. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. The Journal of Experimental Medicine 2001, 194:1277-1287.
39. Surh C.D., Sprent J. Homeostasis of naive and memory T cells. Immunity 2008, 29:848-862.
40. Asquith B., Borghans J.A., Ganusov V.V., Macallan D.C. Lymphocyte kinetics in health and disease. Trends in Immunology 2009, 30:182-189.
41. Napolitano L.A., Grant R.M., Deeks S.G., Schmidt D., De Rosa S.C., Herzenberg L.A., et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nature Medicine 2001, 7:73-79.
42. Fry T.J., Connick E., Falloon J., Lederman M.M., Liewehr D.J., Spritzler J., et al. A potential role for interleukin-7 in T-cell homeostasis. Blood 2001, 97:2983-2990.
43. Fry T.J., Mackall C.L. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. Journal of Immunology 2005, 174:6571-6576.
44. Mackall C.L., Hakim F.T., Gress R.E. Restoration of T-cell homeostasis after T-cell depletion. Seminars in Immunology 1997, 9:339-346.
45. Malaspina A., Moir S., Chaitt D.G., Rehm C.A., Kottilil S., Falloon J., et al. Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7. Blood 2007, 109:2086-2088.
46. Hazenberg M.D., Otto S.A., Cohen Stuart J.W., Verschuren M.C., Borleffs J.C., Boucher C.A., et al. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nature Medicine 2000, 6:1036-1042.
47. Mackall C.L., Fleisher T.A., Brown M.R., Andrich M.P., Chen C.C., Feuerstein I.M., et al. Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 1997, 89:3700-3707.
48. Catalfamo M., Di Mascio M., Hu Z., Srinivasula S., Thaker V., Adelsberger J., et al. HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:19851-19856.
49. Lane H.C. Pathogenesis of HIV infection: total CD4+ T-cell pool, immune activation, and inflammation. Topics in HIV Medicine: A Publication of the International AIDS Society, USA 2010, 18:2-6.
50. Catalfamo M., Wilhelm C., Tcheung L., Proschan M., Friesen T., Park J.H., et al. CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, Type I IFN, and IL-7. Journal of Immunology 2011, 186:2106-2116.
51. Srinivasula S., Lempicki R.A., Adelsberger J.W., Huang C.Y., Roark J., Lee P.I., et al. Differential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes. Blood 2011, 118:262-270.
52. den Braber I., Mugwagwa T., Vrisekoop N., Westera L., Mogling R., Bregje de Boer A., et al. Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans. Immunity 2012, 36:288-297.
53. Douek D.C., Picker L.J., Koup R.A. T cell dynamics in HIV-1 infection. Annual Review of Immunology 2003, 21:265-304.
54. Okoye A.A., Rohankhedkar M., Abana C., Pattenn A., Reyes M., Pexton C., et al. Naive T cells are dispensable for memory CD4+ T cell homeostasis in progressive simian immunodeficiency virus infection. The Journal of Experimental Medicine 2012, 209:641-651.
55. Grossman Z., Meier-Schellersheim M., Paul W.E., Picker L.J. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nature Medicine 2006, 12:289-295.
56. Rochman Y., Spolski R., Leonard W.J. New insights into the regulation of T cells by gamma(c) family cytokines. Nature Reviews Immunology 2009, 9:480-490.
57. Fry T.J., Mackall C.L. Interleukin-7: from bench to clinic. Blood 2002, 99:3892-3904.
58. Mazzucchelli R.I., Warming S., Lawrence S.M., Ishii M., Abshari M., Washington A.V., et al. Visualization and identification of IL-7 producing cells in reporter mice. PLoS One 2009, 4:e7637.
59. O'Shea J.J., Gadina M., Schreiber R.D. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 2002, 109(Suppl.):S121-S131.
60. Mazzucchelli R., Durum S.K. Interleukin-7 receptor expression: intelligent design. Nature Reviews Immunology 2007, 7:144-154.
61. Landires I., Bugault F., Lambotte O., de Truchis P., Slama L., Danckaert A., et al. HIV infection perturbs interleukin-7 signaling at the step of STAT5 nuclear relocalization. AIDS (London, England). 2011, 25:1843-1853.
62. Crawley A.M., Angel J.B. Expression of gamma-chain cytokine receptors on CD8(+) T cells in HIV infection with a focus on IL-7Ralpha (CD127). Immunology and Cell Biology 2012, 90:379-387.
63. Jaleco S., Swainson L., Dardalhon V., Burjanadze M., Kinet S., Taylor N. Homeostasis of naive and memory CD4+ T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis. Journal of Immunology 2003, 171:61-68.
64. Managlia E.Z., Landay A., Al-Harthi L. Interleukin-7 signalling is sufficient to phenotypically and functionally prime human CD4 naive T cells. Immunology 2005, 114:322-335.
65. Fluur C., De Milito A., Fry T.J., Vivar N., Eidsmo L., Atlas A., et al. Potential role for IL-7 in Fas-mediated T cell apoptosis during HIV infection. Journal of Immunology 2007, 178:5340-5350.
66. Rethi B., Vivar N., Sammicheli S., Fluur C., Ruffin N., Atlas A., et al. Priming of T cells to Fas-mediated proliferative signals by interleukin-7. Blood 2008, 112:1195-1204.
67. Takada K., Jameson S.C. Naive T cell homeostasis: from awareness of space to a sense of place. Nature Reviews Immunology 2009, 9:823-832.
68. Schacker T.W., Nguyen P.L., Beilman G.J., Wolinsky S., Larson M., Reilly C., et al. Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis. The Journal of Clinical Investigation 2002, 110:1133-1139.
69. Schacker T.W., Brenchley J.M., Beilman G.J., Reilly C., Pambuccian S.E., Taylor J., et al. Lymphatic tissue fibrosis is associated with reduced numbers of naive CD4+ T cells in human immunodeficiency virus type 1 infection. Clinical and Vaccine Immunology 2006, 13:556-560.
70. van Grevenynghe J., Halwani R., Chomont N., Ancuta P., Peretz Y., Tanel A., et al. Lymph node architecture collapse and consequent modulation of FOXO3a pathway on memory T- and B-cells during HIV infection. Seminars in Immunology 2008, 20:196-203.
71. Zeng M., Smith A.J., Wietgrefe S.W., Southern P.J., Schacker T.W., Reilly C.S., et al. Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections. The Journal of Clinical Investigation 2011, 121:998-1008.
72. van Grevenynghe J., Procopio F.A., He Z., Chomont N., Riou C., Zhang Y., et al. Transcription factor FOXO3a controls the persistence of memory CD4(+) T cells during HIV infection. Nature Medicine 2008, 14:266-274.
73. Zeng M., Southern P.J., Reilly C.S., Beilman G.J., Chipman J.G., Schacker T.W., et al. Lymphoid tissue damage in HIV-1 infection depletes naive T cells and limits T cell reconstitution after antiretroviral therapy. PLoS Pathogens 2012, 8:e1002437.
74. Kovacs J.A., Vogel S., Albert J.M., Falloon J., Davey R.T., Walker R.E., et al. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. The New England Journal of Medicine 1996, 335:1350-1356.
75. Kovacs J.A., Baseler M., Dewar R.J., Vogel S., Davey R.T., Falloon J., et al. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. The New England Journal of Medicine 1995, 332:567-575.
76. Sereti I., Imamichi H., Natarajan V., Imamichi T., Ramchandani M.S., Badralmaa Y., et al. In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients. The Journal of Clinical Investigation 2005, 115:1839-1847.
77. Abrams D., Levy Y., Losso M.H., Babiker A., Collins G., Cooper D.A., et al. Interleukin-2 therapy in patients with HIV infection. The New England Journal of Medicine 2009, 361:1548-1559.
78. Levy Y., Lacabaratz C., Weiss L., Viard J.P., Goujard C., Lelievre J.D., et al. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. The Journal of Clinical Investigation 2009, 119:997-1007.
79. Sereti I., Dunham R.M., Spritzler J., Aga E., Proschan M.A., Medvik K., et al. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood 2009, 113:6304-6314.
80. Imamichi H., Degray G., Asmuth D.M., Fischl M.A., Landay A.L., Lederman M.M., et al. HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy. AIDS (London, England) 2011, 25:159-164.
81. Mueller Y.M., Do D.H., Altork S.R., Artlett C.M., Gracely E.J., Katsetos C.D., et al. IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses. Journal of Immunology 2008, 180:350-360.
82. Picker L.J., Reed-Inderbitzin E.F., Hagen S.I., Edgar J.B., Hansen S.G., Legasse A., et al. IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates. The Journal of Clinical Investigation 2006, 116:1514-1524.
83. Lugli E., Mueller Y.M., Lewis M.G., Villinger F., Katsikis P.D., Roederer M. IL-15 delays suppression and fails to promote immune reconstitution in virally suppressed chronically SIV-infected macaques. Blood 2011, 118:2520-2529.
84. Sneller M.C., Kopp W.C., Engelke K.J., Yovandich J.L., Creekmore S.P., Waldmann T.A., et al. IL-15 administered by continuous infusion to rhesus macaques induces massive expansion of CD8+ T effector memory population in peripheral blood. Blood 2011, 118:6845-6848.
85. Bekisz J., Schmeisser H., Hernandez J., Goldman N.D., Zoon K.C. Human interferons alpha, beta and omega. Growth Factors 2004, 22:243-251.
86. Herbeuval J.P., Nilsson J., Boasso A., Hardy A.W., Kruhlak M.J., Anderson S.A., et al. Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:7000-7005.
87. Herbeuval J.P., Shearer G.M. HIV-1 immunopathogenesis: how good interferon turns bad. Clinical Immunology 2007, 123:121-128.
88. Boasso A., Herbeuval J.P., Hardy A.W., Anderson S.A., Dolan M.J., Fuchs D., et al. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 2007, 109:3351-3359.
89. Boasso A., Shearer G.M. How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation. Current Drug Metabolism 2007, 8:217-223.
90. Boasso A., Hardy A.W., Anderson S.A., Dolan M.J., Shearer G.M. HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation. PLoS One 2008, 3:e2961.
91. Bosinger S.E., Li Q., Gordon S.N., Klatt N.R., Duan L., Xu L., et al. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. The Journal of Clinical Investigation 2009, 119:3556-3572.
92. Jacquelin B., Mayau V., Targat B., Liovat A.S., Kunkel D., Petitjean G., et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. The Journal of Clinical Investigation 2009, 119:3544-3555.
93. Mandl J.N., Barry A.P., Vanderford T.H., Kozyr N., Chavan R., Klucking S., et al. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nature Medicine 2008, 14:1077-1087.
94. Sedaghat A.R., German J., Teslovich T.M., Cofrancesco J., Jie C.C., Talbot C.C., et al. Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferon-mediated disruption of T-cell dynamics. Journal of Virology 2008, 82:1870-1883.
95. Hyrcza M.D., Kovacs C., Loutfy M., Halpenny R., Heisler L., Yang S., et al. Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cells. Journal of Virology 2007, 81:3477-3486.
96. Li Q., Schacker T., Carlis J., Beilman G., Nguyen P., Haase A.T. Functional genomic analysis of the response of HIV-1-infected lymphatic tissue to antiretroviral therapy. The Journal of Infectious Diseases 2004, 189:572-582.
97. Rotger M., Dalmau J., Rauch A., McLaren P., Bosinger S.E., Martinez R., et al. Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. The Journal of Clinical Investigation 2011, 121:2391-2400.
98. Tavel J.A., Huang C.Y., Shen J., Metcalf J.A., Dewar R., Shah A., et al. Interferon-alpha produces significant decreases in HIV load. Journal of Interferon & Cytokine Research 2010, 30:461-464.
99. Lempicki R.A., Polis M.A., Yang J., McLaughlin M., Koratich C., Huang D.W., et al. Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons. The Journal of Infectious Diseases 2006, 193:1172-1177.
100. Palmer S., Josefsson L., Coffin J.M. HIV reservoirs and the possibility of a cure for HIV infection. Journal of Internal Medicine 2011, 270:550-560.
101. Buzon M.J., Massanella M., Llibre J.M., Esteve A., Dahl V., Puertas M.C., et al. HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nature Medicine 2010, 16:460-465.
102. Clarke J.R., Taylor I.K., Fleming J., Nukuna A., Williamson J.D., Mitchell D.M. The epidemiology of HIV-1 infection of the lung in AIDS patients. AIDS (London, England) 1993, 7:555-560.
103. Di Stefano M., Sabri F., Leitner T., Svennerholm B., Hagberg L., Norkrans G., et al. Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment. Journal of Clinical Microbiology 1995, 33:352-355.
104. van't Wout A.B., Ran L.J., Kuiken C.L., Kootstra N.A., Pals S.T., Schuitemaker H. Analysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsy. Journal of Virology 1998, 72:488-496.
105. Chomont N., DaFonseca S., Vandergeeten C., Ancuta P., Sekaly R.P. Maintenance of CD4+ T-cell memory and HIV persistence: keeping memory, keeping HIV. Current Opinion in HIV AIDS 2011, 6:30-36.
106. Baker J.V., Neuhaus J., Duprez D., Kuller L.H., Tracy R., Belloso W.H., et al. Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection. Journal of Acquired Immune Deficiency 2010, 56:36-43.